Raymond James Financial Services Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-20,812
| Closed | -$20K | – | 3382 |
|
|
2023
Q2 | $20K | Buy |
20,812
+8,106
| +64% | +$8.01K | ﹤0.01% | 3173 |
|
|
2023
Q1 | $9.53K | Buy |
12,706
+203
| +2% | +$148 | ﹤0.01% | 3227 |
|
|
2022
Q4 | $4.61K | Sell |
12,503
-431
| -3% | -$182 | ﹤0.01% | 3222 |
|
|
2022
Q3 | $6K | Buy |
12,934
+219
| +2% | +$215 | ﹤0.01% | 3228 |
|
|
2022
Q2 | $10K | Hold |
12,715
| – | – | ﹤0.01% | 3205 |
|
|
2022
Q1 | $16K | Hold |
12,715
| – | – | ﹤0.01% | 3267 |
|
|
2021
Q4 | $16K | Hold |
12,715
| – | – | ﹤0.01% | 3258 |
|
|
2021
Q3 | $28K | Hold |
12,715
| – | – | ﹤0.01% | 3223 |
|
|
2021
Q2 | $48K | Hold |
12,715
| – | – | ﹤0.01% | 3214 |
|
|
2021
Q1 | $41K | Hold |
12,715
| – | – | ﹤0.01% | 3110 |
|
|
2020
Q4 | $43K | Sell |
12,715
-1,750
| -12% | -$7.2K | ﹤0.01% | 2920 |
|
|
2020
Q3 | $59K | Hold |
14,465
| – | – | ﹤0.01% | 2757 |
|
|
2020
Q2 | $49K | Hold |
14,465
| – | – | ﹤0.01% | 2713 |
|
|
2020
Q1 | $34K | Hold |
14,465
| – | – | ﹤0.01% | 2342 |
|
|
2019
Q4 | $53K | Hold |
14,465
| – | – | ﹤0.01% | 2758 |
|
|
2019
Q3 | $120K | Buy |
+14,465
| New | +$117K | ﹤0.01% | 2610 |
|
Raymond James Financial Services Advisors's SPPI Position: Q3 2023 in Review
Raymond James Financial Services Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 20,812 shares — an estimated $20K sold.
Raymond James Financial Services Advisors first reported a position in SPPI in Q3 2019 and held it in 16 quarters. The position peaked at $120K in Q3 2019. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Raymond James Financial Services Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Raymond James Financial Services Advisors sold 20,812 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $20K.
- Raymond James Financial Services Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q3 2019 and held it in 16 quarters.
- Raymond James Financial Services Advisors's Spectrum Pharmaceuticals Inc position peaked at $120K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.